Lilly(Eli) & Co
Lilly(Eli) & Co (LLY) Wheel Strategy
LLY wheel strategy scan found 881 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 84.2%.
Read more
Running a LLY wheel strategy lets you generate consistent premium income on Lilly(Eli) & Co while setting your own entry and exit prices on the underlying. Lilly(Eli) & Co's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own LLY, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best LLY wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on LLY, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable LLY wheel from a losing one.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer.
It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the LLY wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your LLY wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Oct 2, 2026 | 1180.00 | $16.15 | $19.05 | -0.46 | 7 | 37% | 52.3% | 84.2% | 158 |
| Oct 2, 2026 | 1175.00 | $13.00 | $16.35 | -0.42 | 7 | 37% | 56.0% | 72.6% | 97 |
| Oct 9, 2026 | 1180.00 | $22.00 | $26.45 | -0.46 | 14 | 37% | 51.4% | 58.4% | 26 |
| Oct 2, 2026 | 1170.00 | $10.35 | $13.05 | -0.38 | 7 | 37% | 59.6% | 58.2% | 78 |
| Oct 9, 2026 | 1175.00 | $21.05 | $24.80 | -0.43 | 14 | 37% | 54.0% | 55.0% | 49 |
| Oct 2, 2026 | 1165.00 | $7.45 | $11.93 | -0.34 | 7 | 37% | 63.2% | 53.4% | 365 |
| Oct 2, 2026 | 1162.50 | $7.50 | $11.40 | -0.33 | 7 | 37% | 64.9% | 51.1% | 0 |
| Oct 2, 2026 | 1160.00 | $9.10 | $11.30 | -0.32 | 7 | 37% | 66.7% | 50.8% | 182 |
| Oct 9, 2026 | 1170.00 | $16.75 | $21.73 | -0.40 | 14 | 37% | 56.6% | 48.4% | 14 |
| Oct 16, 2026 | 1180.00 | $29.15 | $32.20 | -0.46 | 21 | 37% | 51.0% | 47.4% | 706 |
As of September 25, 2026
Run the Wheel on LLY With Confidence
Find the best LLY wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→